BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 35359389)

  • 1. Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship.
    Slominski RM; Sarna T; Płonka PM; Raman C; Brożyna AA; Slominski AT
    Front Oncol; 2022; 12():842496. PubMed ID: 35359389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities.
    Logesh R; Prasad SR; Chipurupalli S; Robinson N; Mohankumar SK
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188968. PubMed ID: 37657683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current update and trends in melanin pigmentation and melanin biology.
    Jimbow K
    Keio J Med; 1995 Mar; 44(1):9-18. PubMed ID: 7760535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma metastasis: What role does melanin play? (Review).
    Saud A; Sagineedu SR; Ng HS; Stanslas J; Lim JCW
    Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.
    Slominski A; Kim TK; Brożyna AA; Janjetovic Z; Brooks DL; Schwab LP; Skobowiat C; Jóźwicki W; Seagroves TN
    Arch Biochem Biophys; 2014 Dec; 563():79-93. PubMed ID: 24997364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From tyrosine to melanin: Signaling pathways and factors regulating melanogenesis.
    Rzepka Z; Buszman E; Beberok A; Wrześniok D
    Postepy Hig Med Dosw (Online); 2016 Jun; 70(0):695-708. PubMed ID: 27356601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.
    Hida T; Kamiya T; Kawakami A; Ogino J; Sohma H; Uhara H; Jimbow K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis.
    Slominski A; Paus R; Mihm MC
    Anticancer Res; 1998; 18(5B):3709-15. PubMed ID: 9854482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IFPCS presidential lecture: a chemist's view of melanogenesis.
    Ito S;
    Pigment Cell Res; 2003 Jun; 16(3):230-6. PubMed ID: 12753395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round?
    Kadekaro AL; Kavanagh RJ; Wakamatsu K; Ito S; Pipitone MA; Abdel-Malek ZA
    Pigment Cell Res; 2003 Oct; 16(5):434-47. PubMed ID: 12950718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of melanogenesis intermediates.
    Pavel S
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):162S-165S. PubMed ID: 8433003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Melanogenesis by Some Well-Known Polyphenolics: A Review.
    Orhan IE; Deniz FSS
    Curr Pharm Biotechnol; 2021; 22(11):1412-1423. PubMed ID: 33308130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis.
    Ito S; Wakamatsu K; Ozeki H
    Pigment Cell Res; 2000; 13 Suppl 8():103-9. PubMed ID: 11041366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5,6-Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation.
    Del Bino S; Ito S; Sok J; Wakamatsu K
    Pigment Cell Melanoma Res; 2022 Nov; 35(6):622-626. PubMed ID: 35933709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating skin colour: role of the thioredoxin and glutathione systems in regulating melanogenesis.
    Lu Y; Tonissen KF; Di Trapani G
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33871027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.
    Ancans J; Tobin DJ; Hoogduijn MJ; Smit NP; Wakamatsu K; Thody AJ
    Exp Cell Res; 2001 Aug; 268(1):26-35. PubMed ID: 11461115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of melanin monomers, dihydroxyindole-2-carboxylic acid (DHICA) and dihydroxyindole (DHI) on mammalian tyrosinase, with a special reference to the role of DHICA/DHI ratio in melanogenesis.
    Wilczek A; Mishima Y
    Pigment Cell Res; 1995 Apr; 8(2):105-12. PubMed ID: 7659677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole.
    Aroca P; Solano F; Salinas C; García-Borrón JC; Lozano JA
    Eur J Biochem; 1992 Aug; 208(1):155-63. PubMed ID: 1511683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.
    Slominski A; Zbytek B; Slominski R
    Int J Cancer; 2009 Mar; 124(6):1470-7. PubMed ID: 19085934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin does not switch melanin synthesis towards pheomelanin in B16F10 cells.
    Wolnicka-Glubisz A; Nogal K; Żądło A; Płonka PM
    Arch Dermatol Res; 2015 Jan; 307(1):89-98. PubMed ID: 25398276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.